Anlotinib Drives Hepatoblastoma Resistance via GAD1/GABA
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine